109 related articles for article (PubMed ID: 7613637)
21. [The general criteria and recommendations for the elaboration of programs for the early detection of breast cancer and cervical cancer in Spain. The Working Group for the Early Detection of Breast Cancer and Cervical Cancer].
Ascunze Elizaga N; González Enríquez J; González Navarro A; Herranz Fernández C; Marqués Bravo A; Martín Pérez J
Rev Sanid Hig Publica (Madr); 1993; 67(1):23-37. PubMed ID: 7725048
[TBL] [Abstract][Full Text] [Related]
22. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.
Hutchinson ML; Berger BM; Farber FL
Am J Manag Care; 2000 Jul; 6(7):766-80. PubMed ID: 11067374
[TBL] [Abstract][Full Text] [Related]
23. [Screening for cancer].
Caicoya Gómez-Morán M
Aten Primaria; 1995 Oct; 16(7):441-4, 446-52. PubMed ID: 7495955
[No Abstract] [Full Text] [Related]
24. Register-based studies of cancer screening effects.
Von Euler-Chelpin M; Lynge E; Rebolj M
Scand J Public Health; 2011 Jul; 39(7 Suppl):158-64. PubMed ID: 21775376
[TBL] [Abstract][Full Text] [Related]
25. How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands.
Coupé VM; de Melker HE; Snijders PJ; Meijer CJ; Berkhof J
Vaccine; 2009 Aug; 27(37):5111-9. PubMed ID: 19567242
[TBL] [Abstract][Full Text] [Related]
26. The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies.
Holmes J; Hemmett L; Garfield S
Eur J Health Econ; 2005 Mar; 6(1):30-7. PubMed ID: 15682286
[TBL] [Abstract][Full Text] [Related]
27. Concerning the National Breast and Cervical Cancer Early Detection Program.
Kopans DB
AJR Am J Roentgenol; 1998 Jul; 171(1):269. PubMed ID: 9648811
[No Abstract] [Full Text] [Related]
28. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
[TBL] [Abstract][Full Text] [Related]
29. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
May DS; Lee NC; Nadel MR; Henson RM; Miller DS
AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of cervical-cancer screening in five developing countries.
Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
[TBL] [Abstract][Full Text] [Related]
31. Disparities in receipt of breast and cervical cancer screening for rural women age 18 to 64 with disabilities.
Horner-Johnson W; Dobbertin K; Iezzoni LI
Womens Health Issues; 2015; 25(3):246-53. PubMed ID: 25864023
[TBL] [Abstract][Full Text] [Related]
32. [Cervical cancer prevention: the impact of HPV vaccination].
Monsonégo J
Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
[TBL] [Abstract][Full Text] [Related]
33. Multisite cancer screening: a cancer control experience in secondary prevention.
Pearson DK; Rodes ND; Blackwell CW; Perez-Mesa CM
Mo Med; 1981 Dec; 78(12):740-2, 745. PubMed ID: 7339483
[No Abstract] [Full Text] [Related]
34. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting uptake of cervical and breast cancer screening among perimenopausal women in Hong Kong.
Chan C; Ho SC; Chan SG; Yip YB; Wong FC; Cheng F
Hong Kong Med J; 2002 Oct; 8(5):334-41. PubMed ID: 12376710
[TBL] [Abstract][Full Text] [Related]
36. An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China.
Levin CE; Sharma M; Olson Z; Verguet S; Shi JF; Wang SM; Qiao YL; Jamison DT; Kim JJ
Vaccine; 2015 Jun; 33(24):2830-41. PubMed ID: 25770785
[TBL] [Abstract][Full Text] [Related]
37. [Simultaneous screening of cancers of the breast, cervix, colon and rectum. The Isère experience].
Exbrayat C; Garnier A; Bolla M; Winckel P; Salicru B; Marron J; Faure H; Menegoz F; Billette de Villemeur A
Bull Cancer; 1996 Aug; 83(8):641-8. PubMed ID: 8869044
[TBL] [Abstract][Full Text] [Related]
38. Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer.
Wu JC; Hakama M; Anttila A; Yen AM; Malila N; Sarkeala T; Auvinen A; Chiu SY; Chen HH
Breast Cancer Res Treat; 2010 Jul; 122(2):553-66. PubMed ID: 20054645
[TBL] [Abstract][Full Text] [Related]
39. A review of the technical features of breast cancer screening illustrated by a specific model using South Australian cancer registry data.
O'Neill TJ; Tallis GM; Leppard P
Stat Methods Med Res; 1995 Mar; 4(1):55-72. PubMed ID: 7613638
[TBL] [Abstract][Full Text] [Related]
40. The evaluation of cancer control measures.
Boyes DA; Knowelden J; Phillips AJ
Br J Cancer; 1973 Aug; 28(2):105-7. PubMed ID: 4730175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
